FDA Inspection
Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc.FDA Inspection 1086261 - Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc. - April 12, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc., with an inspection on April 12, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 12, 2019
- Product Type
- Drugs
Open in Dashboard
ID · b2f87b25-025a-4bc6-9a7b-4f3d027305ea
Violation Codes4
21 CFR 211.186(a)21 CFR 211.19221 CFR 211.68(a)21 CFR 211.80(b)
Full citation text and observation details available on the Dashboard.